David leads OVID’s Public Affairs practice. David has spent over a decade in public affairs, advising a wide range of life science companies in the UK and globally. He has delivered strategic communications and public affairs campaigns for several leading pharmaceutical companies, including clients in the oncology space.​ He advised Novartis Oncology for two years, including on campaigns on ‘How to retain the Cancer Drugs Fund’ – a key revenue pipeline for their portfolio. He also worked with them to raise parliamentary awareness of neuroendocrine cancers. He helps clients navigate and shape an increasingly complex UK healthcare landscape.

Richard is responsible for ensuring the agency runs smoothly. Over the past five years Richard has created bespoke platforms for OVID which mean we have some of the best systems in the business including industry-leading IT and data security. As a degree-qualified professional engineer, Richard has a strong background in technology, finance and project management. Prior to OVID, Richard worked as Vice President of R&D at a global engineering firm, leading major infrastructure projects as well as roles in the manufacturing and transport sectors. He has a passion for STEM education and is experienced handling procurement with large and medium-sized pharmaceutical companies. ​

Along with events and marketing administrative experience, Jenna holds a postgraduate degree in Drug Discovery and Pharmaceutical Management from University College London. Her dissertation focused on the primary market access challenges associated with emerging technologies for managing type 1 diabetes.

Oliver is a Biotechnology and Enterprise graduate with experience in health policy, social media comms and public affairs. He joined OVID from Freuds where he supported COVID-19 vaccine awareness campaigns for the Cabinet Office (liaising with social media influencers and content influencers); as well as working for Public Health England on an obesity awareness programme. Oliver spent a year in Pfizer’s policy and public affairs team working across multiple therapy areas, including rare diseases. He also operated as an enterprise consultant to a MedTech start-up in Far-UVC products after graduation. 

Anna joined OVID from a global communications agency Clarity Global, where she worked in the Public Affairs Team, specialising in Health Technology. Working across global MedTech accounts and leading the Health Tech Alliance, she specialised in market access, policy advocacy and project management. During her time in agency, Anna managed parliamentary engagement and roundtables, project-style lobbying and market access campaigns, as well as NHSE and arms-length body relations. Before entering consultancy, Anna worked as a Communications Officer for a Member of Parliament

Rachael is our Deputy Head of Patient Partnerships and has over 10-years of policy and public affairs experience in the health and life sciences sectors. Prior to working in consultancy, Rachael held several in-house roles working with global pharmaceutical companies, biotech start-ups, medical research charities and academic organisations.    

Between 2016 and 2018, Rachael managed the Bioindustry Association’s public affairs activities during the fallout of the EU referendum and the development of the 2017 Life Sciences Industrial Strategy. She also led the organisation’s policy development on rare diseases, cell and gene therapies and genomics, including establishing the UK’s Rare Disease Industry Group – a coalition of pharmaceutical companies which continues to advocate for better access to orphan medicines.  

In 2019, Rachael moved to the Francis Crick Institute, a world-renowned biomedical research centre, to take on the role of strategic adviser to the Institute’s Director and Nobel Laureate, Sir Paul Nurse.  

Rachael joined consultancy in 2021 and she particularly enjoys working with clients to make complex scientific topics easy for policymakers and members of the public to understand.  

Jen is an International Relations graduate, and holds a Postgraduate degree in Security Studies where her dissertation  covered the use of Twitter and political campaigning by the Russian Federation in the Ukrainian War. Prior to this, she lived for several years in Spain where she worked as an English teacher. In her previous role she worked as an intern in an agency, working with clients from a variety of sectors, including health, housing and energy. 

Emma has over 9 years of experience in healthcare policy, advocacy and communications at a UK, Australian and global level. She has joined OVID from MHP Group where she led a series of award-winning oncology campaigns focusing on patient advocacy, value assessments, and lung cancer where she worked to establish partnerships with the World Economic Forum. Emma has considerable UK policy knowledge, working for the British Medical Association as a Senior Advisor focusing on social care policy and devolved nations spending. Before emigrating to the UK, she was a Special Advisor to an Australian Health Minister leading multiple campaigns and legislative changes in health and social welfare.

Sean has five years’ experience advising clients in the health sector, including medical societies, non-profit organisations and pharmaceutical companies. He previously advised at MHP, emotive and Spink agencies, where he led strategy development, campaign execution and client relationships at a UK, European and global level. His clients have included AstraZeneca, United European Gastroenterology, Bowel Research UK and BEAMA. He has extensive experience in media relations and has secured coverage in publications across the UK and Europe.

Will has worked in healthcare communications for nearly seven years, advising healthcare clients in oncology, diabetes, immunology, rare diseases and more.

While his area of expertise is communications and media relations, Will’s experience is diverse and spans media and digital campaigning, data communications, issues management, patient engagement, clinical trial recruitment, stakeholder management, medical education, gaming and market research.

Prior to OVID, Will advised healthcare clients at Aurora.

Will is currently Co-Lead of the Healthcare Communications Association (HCA) Future Leaders group where he is tapped into a number of ongoing industry communications initiatives and networks.

Will graduated from Newcastle University in 2017 and spent the Summer as a research assistant at the School of Politics, interviewing policy and public stakeholders and developing insights reports.

Carys joins OVID as a Junior Account executive after graduating from the University of Bristol, where she tailored her History degree to explore patient experiences of health and disease. Her dissertation explored the mobilisation of health politics through media, examining its importance in enabling the communication and contestation of women’s negative gynaecological experiences to bolster the Women’s Health Movement. In her final year, she was also employed as a research assistant by Bristol and Warwick universities to formulate strategies in increasing student engagement with the Department.​​